MyHealthChecked (MHC) Competitors

Belluscura (LON:BELL) and MyHealthChecked (LON:MHC) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, community ranking, analyst recommendations, institutional ownership, media sentiment and dividends.

Does the media refer more to BELL or MHC?

In the previous week, Belluscura's average media sentiment score of 0.00 equaled MyHealthChecked'saverage media sentiment score.

Company	Overall Sentiment
Belluscura	Neutral
MyHealthChecked	Neutral

Is BELL or MHC more profitable?

Belluscura has a net margin of 0.00% compared to MyHealthChecked's net margin of -11.06%. MyHealthChecked's return on equity of -12.92% beat Belluscura's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Belluscura	N/A	-85.01%	-43.53%
MyHealthChecked	-11.06%	-12.92%	-8.18%

Do institutionals & insiders hold more shares of BELL or MHC?

6.3% of Belluscura shares are owned by institutional investors. Comparatively, 3.1% of MyHealthChecked shares are owned by institutional investors. 56.3% of Belluscura shares are owned by insiders. Comparatively, 53.6% of MyHealthChecked shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Does the MarketBeat Community favor BELL or MHC?

Belluscura and MyHealthChecked both received 0 outperform votes by MarketBeat users.

Company	Underperform	Outperform
Belluscura	N/A	N/A
MyHealthChecked	N/A	N/A

Which has better valuation and earnings, BELL or MHC?

MyHealthChecked has higher revenue and earnings than Belluscura. MyHealthChecked is trading at a lower price-to-earnings ratio than Belluscura, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Belluscura	£1.80M	8.98	-£18.60M	-£0.10	-96.00
MyHealthChecked	£9.39M	0.59	-£1.04M	-£0.02	-528.25

Which has more volatility & risk, BELL or MHC?

Belluscura has a beta of 1.05, indicating that its stock price is 5% more volatile than the S&P 500. Comparatively, MyHealthChecked has a beta of 1.37, indicating that its stock price is 37% more volatile than the S&P 500.

Summary

MyHealthChecked beats Belluscura on 6 of the 11 factors compared between the two stocks.